Sign Up Today and Learn More About AdjuCor Stock
Invest in or calculate the value of your shares in AdjuCor or other pre-IPO companies through EquityZen's platform.
AdjuCor Stock (ADJU)
Medtech company commercializing a revolutionary cardiac assist device: biventricular and without blood-contact
About AdjuCor Stock
Founded
2012
Industries
Software, Artificial Intelligence, Data and Analytics
AdjuCor Press Mentions
Stay in the know about the latest news on AdjuCor
Conformable sheath for a medical implant
patents • Apr 14, 2024
German Start-up AdjuCor Marks Milestone with Successful First-in-Human Implantations of reBEAT System
prweb • Oct 27, 2023
AdjuCor Launches EU Co-Funded Project for Accelerating Market Entrance of reBEAT, their Innovative Cardiac Support Device
prweb • Oct 27, 2023
AdjuCor Raises € 29 Million in Series B Funding Round for its Revolutionary Heart Assist Technology that Completely Avoids Blood Contact
prweb • Oct 27, 2023
AdjuCor Announces First Successful In Vivo 60-Day Pre-Clinical Survival Study using its Cutting-edge Non-blood-contacting, Biventricular Cardiac Support Device.
businesswire • Jul 13, 2020
AdjuCor Management
Leadership team at AdjuCor
CTO and CPO
Andreas Maier
Co-Founder and CEO
Stephen Wildhirt
Join now and verify your accreditation status to gain access to:
- AdjuCor current valuation
- AdjuCor stock price
- Available deals in AdjuCor and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading AdjuCor Stock
How to invest in AdjuCor stock?
Accredited investors can buy pre-IPO stock in companies like AdjuCor through EquityZen funds. These investments are made available by existing AdjuCor shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell AdjuCor stock?
Shareholders can sell their AdjuCor stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
